Who we are
CILCARE is dedicated to harnessing its expertise in auditory sciences to more precisely define, detect and treat auditory-related diseases
Leveraging a decade of R&D in inner ear therapeutics, CILcare has developed a groundbreaking approach to translate advanced science in hearing disorders coupled with auditory signature and real-world evidence into novel therapies.
While hearing loss has been ranked as the 3rd most common cause of YLDs, more and more studies have highlighted linking to other chronic disabling conditions such as Alzheimer’s disease, diabetes, cardiovascular diseases and many more. A growing body of research has shown that hearing loss confers an independent risk of dementia, which could be a harbinger of declining cognitive function.
In less than a decade, CILcare has generated a massive set of preclinical auditory data on various auditory models. Combined with real-world data, we believe that these auditory digital signatures will be at the heart to develop new targeted therapies of age-related hearing disorders.
CILCARE has also been a catalyst for drug development in hearing disorders since its inception in 2014. Established in Boston, Paris, and Montpellier, CILcare provides its smart R&D platform as a research-for-hire to the top hearing research companies, pharmaceutical, medical devices and veterinary industries, as well as academic institutions across the US, Europe and Asia.
Our state-of-the-art laboratories and research experts in otology and neurosciences enables us to offer fully customizable and comprehensive R&D program including pharmacokinetics, preclinical efficacy, and GLP ototoxicity studies.
A trusted partner with the ambition to provide effective treatments to millions of patients suffering from ear diseases, on a global scale, join us as we fight for this cause: The care of this extraordinary sense: hearing.
Dedicating and innovating, always answering our clients’ and partners’ needs is our priority.
CILcare is ISO 9001:2015 certified.
Learn more about CILcare’s Quality Policy.